IL144381A - S-nitrosothiols as agents for the treatment of circulatory dysfunctions - Google Patents

S-nitrosothiols as agents for the treatment of circulatory dysfunctions

Info

Publication number
IL144381A
IL144381A IL14438100A IL14438100A IL144381A IL 144381 A IL144381 A IL 144381A IL 14438100 A IL14438100 A IL 14438100A IL 14438100 A IL14438100 A IL 14438100A IL 144381 A IL144381 A IL 144381A
Authority
IL
Israel
Prior art keywords
nitrosothiols
agents
treatment
dysfunctions
circulatory
Prior art date
Application number
IL14438100A
Other languages
English (en)
Other versions
IL144381A0 (en
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of IL144381A0 publication Critical patent/IL144381A0/xx
Publication of IL144381A publication Critical patent/IL144381A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IL14438100A 1999-01-27 2000-01-19 S-nitrosothiols as agents for the treatment of circulatory dysfunctions IL144381A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009900159A ES2147162B1 (es) 1999-01-27 1999-01-27 "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias".
PCT/ES2000/000019 WO2000044714A1 (es) 1999-01-27 2000-01-19 S-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias

Publications (2)

Publication Number Publication Date
IL144381A0 IL144381A0 (en) 2002-05-23
IL144381A true IL144381A (en) 2005-08-31

Family

ID=8307080

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14438100A IL144381A (en) 1999-01-27 2000-01-19 S-nitrosothiols as agents for the treatment of circulatory dysfunctions

Country Status (37)

Country Link
US (1) US6800612B2 (de)
EP (1) EP1157987B1 (de)
JP (1) JP3795330B2 (de)
KR (1) KR100671878B1 (de)
CN (1) CN1166631C (de)
AP (1) AP1439A (de)
AT (1) ATE249428T1 (de)
AU (1) AU764725B2 (de)
BG (1) BG64983B1 (de)
BR (1) BR0007395B1 (de)
CA (1) CA2359027C (de)
CU (1) CU23098A3 (de)
CZ (1) CZ298871B6 (de)
DE (2) DE60005154T2 (de)
DK (1) DK1157987T3 (de)
EA (1) EA003577B1 (de)
EE (1) EE04524B1 (de)
ES (2) ES2147162B1 (de)
GB (1) GB2363604B (de)
GE (1) GEP20043220B (de)
HK (1) HK1043586A1 (de)
HR (1) HRP20010562B1 (de)
HU (1) HUP0105203A3 (de)
ID (1) ID29777A (de)
IL (1) IL144381A (de)
IS (1) IS2153B (de)
MX (1) MXPA01007570A (de)
NO (1) NO326806B1 (de)
NZ (1) NZ513162A (de)
OA (1) OA11823A (de)
PL (1) PL202372B1 (de)
PT (1) PT1157987E (de)
RS (1) RS50072B (de)
SI (1) SI1157987T1 (de)
TR (1) TR200102003T2 (de)
WO (1) WO2000044714A1 (de)
ZA (1) ZA200106182B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173044B1 (es) * 2001-03-13 2004-01-16 Lacer Sa Derivados de glicina, n-(n-l-gamma-glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
JP2007518697A (ja) * 2003-09-26 2007-07-12 ニトロメッド インコーポレーティッド ニトロソ化グルタミン酸化合物、組成物、および使用方法
EP1939179A1 (de) * 2006-12-28 2008-07-02 Lacer, S.A. Stabile S-Nitrosothiole, Syntheseverfahren und Verwendung
WO2009050527A1 (en) 2007-10-17 2009-04-23 Biotech Hungary Kutató És Fejlesztési Kft. Pharmaceutical composition comprising s-nitrosoglutathione and polysaccharide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US37839A (en) * 1863-03-03 Improved spoke-machine
GB1567561A (en) 1977-01-18 1980-05-14 Ucb Sa Amino-spiro(oxa-(orthia)cycloalkane-penam) - carboxylic acids
GB2052497B (en) 1979-06-25 1983-06-29 Ucb Sa 6 - amino - spiro - (penam - 2,4' - piperidine) - 3 - carboxylic acid derivatives
DE3805965A1 (de) 1988-02-25 1989-09-07 Tamas Geb Szenasi Eszter Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
US5025001A (en) 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
DE69008454T2 (de) * 1989-08-07 1994-08-25 Takeda Chemical Industries Ltd Nitrolsothiolderivate, ihre Herstellung und Verwendung.
DE69123428T2 (de) 1990-04-26 1997-05-15 Senju Pharma Co Inhibitor von lebererkrankungen
US5187305A (en) * 1990-11-26 1993-02-16 Glaxo Inc. S-nitroso-N-alkonoylpenicillamines
DK0676964T3 (da) 1991-11-14 2001-02-05 Brigham & Womens Hospital Nitrosylering af enzym-SH-grupper som en terapeutisk modalitet
NZ248332A (en) 1992-08-07 1995-01-27 Sankyo Co Hiv protease inhibitor and its use
AU698748B2 (en) * 1993-09-17 1998-11-05 Brigham And Women's Hospital Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
AU704173B2 (en) 1993-11-02 1999-04-15 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
GB9423868D0 (en) 1994-11-25 1995-01-11 Wellcome Found Compounds for use in medicine
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
AU6782198A (en) 1997-03-27 1998-10-20 Trustees Of Boston University Novel antiplatelet agent

Also Published As

Publication number Publication date
DE60005154D1 (de) 2003-10-16
AP2001002247A0 (en) 2001-09-30
PL349006A1 (en) 2002-06-17
NO20013385D0 (no) 2001-07-06
EA003577B1 (ru) 2003-06-26
CZ298871B6 (cs) 2008-02-27
CA2359027A1 (en) 2000-08-03
KR20010101767A (ko) 2001-11-14
DE60005154T2 (de) 2004-07-08
IL144381A0 (en) 2002-05-23
SI1157987T1 (en) 2004-02-29
ES2147162B1 (es) 2001-03-16
GB2363604A (en) 2002-01-02
ATE249428T1 (de) 2003-09-15
GEP20043220B (en) 2004-04-26
NZ513162A (en) 2003-01-31
WO2000044714A1 (es) 2000-08-03
ZA200106182B (en) 2002-10-28
NO20013385L (no) 2001-09-17
HRP20010562B1 (en) 2010-08-31
IS2153B (is) 2006-10-13
HUP0105203A2 (en) 2002-06-29
NO326806B1 (no) 2009-02-16
YU53601A (sh) 2004-03-12
AP1439A (en) 2005-06-27
PL202372B1 (pl) 2009-06-30
DE10083902T1 (de) 2002-01-10
MXPA01007570A (es) 2003-05-14
BR0007395B1 (pt) 2010-11-16
EP1157987B1 (de) 2003-09-10
CA2359027C (en) 2008-10-28
BG105824A (en) 2002-06-28
US20020058629A1 (en) 2002-05-16
AU3046000A (en) 2000-08-18
CN1166631C (zh) 2004-09-15
GB0120581D0 (en) 2001-10-17
HUP0105203A3 (en) 2002-08-28
US6800612B2 (en) 2004-10-05
CU23098A3 (es) 2005-11-18
TR200102003T2 (tr) 2001-12-21
OA11823A (en) 2005-08-16
ID29777A (id) 2001-10-11
IS6020A (is) 2001-07-23
HRP20010562A2 (en) 2002-08-31
ES2206178T3 (es) 2004-05-16
AU764725B2 (en) 2003-08-28
JP2002535385A (ja) 2002-10-22
BG64983B1 (bg) 2006-11-30
HK1043586A1 (en) 2002-09-20
PT1157987E (pt) 2004-01-30
GB2363604B (en) 2003-09-10
JP3795330B2 (ja) 2006-07-12
BR0007395A (pt) 2001-10-30
RS50072B (sr) 2009-01-22
CN1337946A (zh) 2002-02-27
DK1157987T3 (da) 2003-11-24
CZ20012678A3 (cs) 2001-10-17
EP1157987A1 (de) 2001-11-28
KR100671878B1 (ko) 2007-01-19
EE04524B1 (et) 2005-08-15
EA200100823A1 (ru) 2002-02-28
ES2147162A1 (es) 2000-08-16
EE200100389A (et) 2002-12-16

Similar Documents

Publication Publication Date Title
IL146162A0 (en) Macrolide compounds for the treatment of dry eye
GB9925136D0 (en) Novel treatment
IL144186A0 (en) Novel treatment
IL133760A0 (en) Composition for the treatment of dandruff
GB2354944B (en) Skin treatment compositions
AP2001002247A0 (en) S-nitrosothiols as agents for the treatment of circulatory dysfunctions
HRP20020262B1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
HU0001891D0 (en) Medicament for the treatment of migraine
GB9904252D0 (en) Composition for the treatment of pain
GB9929695D0 (en) Fabric treatment composition
GB9927504D0 (en) Fabric treatment
GB0206401D0 (en) Side effects treatment
SI1224181T1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer
GB9924980D0 (en) Therapeutic treatment
GB9901505D0 (en) Therapeutic treatment
GB9908993D0 (en) Treatment
GB9925550D0 (en) Glaucoma treatment
GB9919126D0 (en) Glaucoma treatment
GB9917160D0 (en) Maldour treatment compositions
GB9915235D0 (en) Liquid treatment agents
GB9909650D0 (en) Novel treatment
GB9920787D0 (en) Novel treatment
GB9916655D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
AU138987S (en) Treatment table

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees